REPORT FROM THE 9th INTERNATIONAL CONFERENCE AD/PD, PRAGUE, CZECH REPUBLIC, MARCH 11-15, 2009 – The dopaminergic system is involved in mediating the effects of stress on motor function, which may explain the observation that stress can lead to the onset of parkinsonian symptoms or accelerate the progression of Parkinsons disease.
Neurology
Comparing treatments for behavioural and psychological symptoms
August 11, 2009REPORT FROM THE 9th INTERNATIONAL CONFERENCE AD/PD, PRAGUE, CZECH REPUBLIC, MARCH 11-15, 2009 – A single-centre open trial in Sweden has compared the use of galantamine and risperidone for the treatment of behavioural and psychological symptoms in dementia (BPSD) (Freund-Levi. AD/PD; 1290).
Diabetes a risk factor for MCI, Alzheimers disease
August 11, 2009REPORT FROM THE 9th INTERNATIONAL CONFERENCE AD/PD, PRAGUE, CZECH REPUBLIC, MARCH 11-15, 2009 – German researchers have analysed data from the Longitudinal Study on Adult Development and Aging to assess the impact of type 2 diabetes on the development of mild cognitive impairment (MCI) and Alzheimers disease (Toro et al. AD/PD; 427; published as Toro et al. J Alzheimers Dis 2009;16: 687-691)). All subjects were born in the period 1930-1932.
Alzheimer’s disease and HMG CoA reductase variants
August 11, 2009REPORT FROM THE 9th INTERNATIONAL CONFERENCE AD/PD, PRAGUE, CZECH REPUBLIC, MARCH 11-15, 2009 – Genetic variants in HMG CoA reductase may influence the risk of Alzheimers disease, according to the results of a study of French Canadians from Eastern Canada (Legault et al. AD/PD; 1626).
Predictors of response: results from long-term follow-up
July 21, 2009REPORT FROM THE 2009 AAN ANNUAL MEETING – Early progression of disability, a high relapse rate and ongoing MRI activity appear to be indicators of an inadequate response to disease-modifying therapy, according to the 15-year follow-up results of the MS Collaborative Study Group pivotal trial of beta-interferon-1a (Avonex) (Bermel et al. AAN 2009; abstract P02.117).
Read More